Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/07/2007 | US20070128166 Expression vector comprising cytomegalo virus promoter, tumor suppressor region, terminal repeat and conditional sucide gene sequences for use in targeting and destruction of tumor cells; antitumor agents; gene therapy |
06/07/2007 | US20070128165 Recombinase-Based System for Expression of Foreign Proteins Using Adenovirus Vectors |
06/07/2007 | US20070128164 Poxvirus vector comprising 5T4 tumour-associated antigen (TAA) for vaccinating cell against cell proliferative disorders |
06/07/2007 | US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors |
06/07/2007 | US20070128162 Alpha interferon variants |
06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
06/07/2007 | CA2670801A1 Compositions and methods of using sirna to knockdown gene expression and to improve solid organ and cell transplantation |
06/07/2007 | CA2638983A1 Alzheimer's disease animal model, method for obtaining same and uses thereof |
06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
06/07/2007 | CA2632859A1 Methods for gene mapping and haplotyping |
06/07/2007 | CA2632794A1 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
06/07/2007 | CA2632152A1 Neuregulin variants and methods of screening and using thereof |
06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
06/07/2007 | CA2631781A1 Novel hydroxysteroid dehydrogenase gene for alteration of plant phenotype |
06/07/2007 | CA2631779A1 Plants having improved growth characteristics and methods for making the same |
06/07/2007 | CA2631677A1 Amphoteric liposome formulation |
06/07/2007 | CA2631587A1 Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
06/07/2007 | CA2631406A1 Grg23 and grg51 genes conferring herbicide resistance |
06/07/2007 | CA2631400A1 Process for the production, in prokaryotes, of active, stable transposases of mariner mobile genetic elements |
06/07/2007 | CA2631382A1 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
06/07/2007 | CA2631322A1 Method of modifying chromosome |
06/07/2007 | CA2631195A1 Monoclonal antibodies against amyloid beta protein and uses thereof |
06/07/2007 | CA2631062A1 Method for identifying a modulator of a cell signalling pathway |
06/07/2007 | CA2630455A1 Dna binding site of a transcriptional activator useful in gene expression |
06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
06/07/2007 | CA2628959A1 Methods for production of receptor and ligand isoforms |
06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
06/06/2007 | EP1793005A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF |
06/06/2007 | EP1793004A1 Method of forming signal probe polymer |
06/06/2007 | EP1793001A2 Yeast screens for agents affecting protein folding |
06/06/2007 | EP1793000A1 Transgenically produced non-secreted proteins |
06/06/2007 | EP1792998A2 An unusual retrotransposon from the yeast Candida albicans |
06/06/2007 | EP1792997A1 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
06/06/2007 | EP1792996A1 Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
06/06/2007 | EP1792995A2 Chlamydia secretory locus orf and uses thereof |
06/06/2007 | EP1792994A2 Vaccines of bacterial outer membrane vesicles |
06/06/2007 | EP1792993A1 Transformation systems for the yeast candida utilis and the expression of heterologous genes therewith |
06/06/2007 | EP1792992A1 Antigenic protein originating in Malassezia |
06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
06/06/2007 | EP1792990A2 Nucleid acids isolated in neuroblastoma |
06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
06/06/2007 | EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer |
06/06/2007 | EP1792987A1 Method of producing glycoprotein composition |
06/06/2007 | EP1792986A1 Novel carbonyl reductase, gene thereof and method of using the same |
06/06/2007 | EP1792985A1 Cell fusion promoter and utilization of the same |
06/06/2007 | EP1792984A1 Microorganism of corynebacterium genus having resistance to kanamycin and enhanced L-lysine productivity and method of producing L-lysine using the same |
06/06/2007 | EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof |
06/06/2007 | EP1792982A2 Codon-optimised alkaline phosphatase and its expression in yeast |
06/06/2007 | EP1792981A1 Microginin producing proteins and nucleic acids encoding a microginin gene cluster as well as methods for creating microginins |
06/06/2007 | EP1792916A1 TAAR1 transgenic animal |
06/06/2007 | EP1792914A1 Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants |
06/06/2007 | EP1792913A1 Novel secreted and membrane-associated proteins and uses therefor |
06/06/2007 | EP1792912A2 Novel proteins and nucleic acids encoding same |
06/06/2007 | EP1792626A1 Treatment of obesity by brain delivery of alpha-MSH and analogs thereof |
06/06/2007 | EP1792537A1 Method of constructing clone mammal |
06/06/2007 | EP1791980A2 Reverse transfection of cell arrays for structural and functional analyses of proteins |
06/06/2007 | EP1791978A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
06/06/2007 | EP1791975A1 Compositions and methods for phage display of polypeptides |
06/06/2007 | EP1791968A2 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
06/06/2007 | EP1791964A2 Biotic and abiotic stress tolerance in plants |
06/06/2007 | EP1791963A2 Modulation of flowering time and growth cessation in perennial plants |
06/06/2007 | EP1791962A2 Promoter molecules isolated from brassica napus for use in plants |
06/06/2007 | EP1791961A1 Protein production method utilizing yebf |
06/06/2007 | EP1791960A2 Optimized nucleotide sequences encoding sgp 130 |
06/06/2007 | EP1791959A2 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
06/06/2007 | EP1791958A2 Yeast/bacterial two-hybrid system and methods of use thereof |
06/06/2007 | EP1791957A1 Prohibitin as target for cancer therapy |
06/06/2007 | EP1791956A1 Oligonucleotide for detection of microorganism diagnostic kits and methods for detection of microorganis using the oligonucleotide |
06/06/2007 | EP1791955A2 Twodimensional strandness- and length-dependent separation of nucleic acid fragments |
06/06/2007 | EP1791954A1 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
06/06/2007 | EP1791945A1 Stable liquid formulations of plasmid dna |
06/06/2007 | EP1791867A2 Binding member towards pneumolysin |
06/06/2007 | EP1791865A2 Cells expressing a modified t cell receptor |
06/06/2007 | EP1791861A1 Protein regulating leaf longevity of plants, the gene thereof and their use |
06/06/2007 | EP1791859A1 Chemokine binding activity of viral tnf receptors and related proteins |
06/06/2007 | EP1791568A2 Therapeutic uses of inhibitors of rtp801 |
06/06/2007 | EP1791418A1 Method and apparatus for substantially isolating plant tissues |
06/06/2007 | EP1791417A2 Polynucleotides, dna constructs and methods for the alteration of plant lignin content and/or composition |
06/06/2007 | EP1718751A4 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
06/06/2007 | EP1648936B1 Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor |
06/06/2007 | EP1638732A4 Methods and systems for processing microfeature workpieces with flow agitators and/or multiple electrodes |
06/06/2007 | EP1620459A4 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
06/06/2007 | EP1571896A4 Transgenic high tryptophan plants |
06/06/2007 | EP1537233B1 Gtp cyclohydrolase ii as a target for fungicides |
06/06/2007 | EP1490511A4 Methods and systems for dynamic gene expression profiling |
06/06/2007 | EP1487998B1 Methods for diagnosing and treating schizophrenia |
06/06/2007 | EP1485505A4 Melting temperature dependent dna amplification |
06/06/2007 | EP1476548B1 Process of cell electrofusion |
06/06/2007 | EP1402034B1 Identification of ses-1 and the uses of the same |
06/06/2007 | EP1392254B1 Micellar drug delivery systems for hydrophobic drugs |
06/06/2007 | EP1379660B1 Self-replicating rna molecule from hepatitis c virus |
06/06/2007 | EP1373467A4 Device and method for detection of multiple analytes |
06/06/2007 | EP1363601B1 Amphoteric liposomes and the use thereof |
06/06/2007 | EP1354046B1 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors |
06/06/2007 | EP1331272B1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
06/06/2007 | EP1297123B1 Method for genome mining for secreted protein genes |
06/06/2007 | EP1276870B1 Method for obtaining plants exhibiting enhanced resistance to water stress |
06/06/2007 | EP1264181B1 Carriers coated with polysaccharides, their preparation and use |
06/06/2007 | EP1230378B1 An oncolytic adenovirus |
06/06/2007 | EP1181056B1 Lim mineralization protein splice variants |